Growth Metrics

Rockwell Medical (RMTI) Accumulated Depreciation & Amortization (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Accumulated Depreciation & Amortization for 14 consecutive years, with $1.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Accumulated Depreciation & Amortization rose 0.55% year-over-year to $1.6 million, compared with a TTM value of $1.6 million through Sep 2025, up 0.55%, and an annual FY2024 reading of $2.2 million, up 50.97% over the prior year.
  • Accumulated Depreciation & Amortization was $1.6 million for Q3 2025 at Rockwell Medical, up from $1.1 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $2.2 million in Q4 2024 and bottomed at $138000.0 in Q1 2022.
  • Average Accumulated Depreciation & Amortization over 5 years is $777684.2, with a median of $545000.0 recorded in 2024.
  • The sharpest move saw Accumulated Depreciation & Amortization plummeted 31.68% in 2022, then surged 240.62% in 2024.
  • Year by year, Accumulated Depreciation & Amortization stood at $668000.0 in 2021, then fell by 13.77% to $576000.0 in 2022, then skyrocketed by 150.69% to $1.4 million in 2023, then skyrocketed by 50.97% to $2.2 million in 2024, then dropped by 24.5% to $1.6 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for RMTI at $1.6 million in Q3 2025, $1.1 million in Q2 2025, and $539000.0 in Q1 2025.